2 %Among Kenyan adolescents aged 15–19 years in Kisumu, 2% had used HIV pre-exposure prophylaxis (PrEP).
KenyaVIH/sidapublished 2024Journal of acquired immune deficiency syndromes (1999)PubMeddocument of 15 observations
Gold tier: mechanically validated evidence, with its primary source.
6,677 evidence items · page 24 / 268
2 %Among Kenyan adolescents aged 15–19 years in Kisumu, 2% had used HIV pre-exposure prophylaxis (PrEP).
KenyaVIH/sidapublished 2024Journal of acquired immune deficiency syndromes (1999)PubMeddocument of 15 observations
9.2 odds_ratioThere was more plaque present in cases than controls with odds ratio = 9.2.
KenyaPeriodontitispublished 2014IOSR Journal of Dental and Medical SciencesOpenAlexdocument of 9 observations
0.3 %Ethionamide resistance among HIV-negative tuberculosis patients in Western Kenya was 0.3%.
Kenyatuberculosepublished 2021BMC infectious diseasesPubMeddocument of 23 observations
0.03 USDIf implemented nationally, the cost per additional child correctly managed was estimated at 0.03 USD.
Kenyapaludismeobserved 2010published 2012PloS oneeurope_pmcdocument of 5 observations
0.81 odds_ratioDantu was associated with protection from all-cause bacteremia with an odds ratio of 0.81 (P = .014).
Kenyabacteraemiaobserved 1998 and 2010published 2025The Journal of infectious diseasesPubMeddocument of 3 observations
90 %Among ART-eligible persons in care, year 3 viral suppression was 90% in the intervention arm and 87% in the control arm.
KenyaVIH/sidapublished 2020Journal of acquired immune deficiency syndromes (1999)PubMeddocument of 4 observations
3.7 %The cumulative HIV prevalence was 3.7% among patients admitted with laboratory-confirmed COVID-19 infection at Aga Khan University Hospital, Nairobi.
KenyaCOVID-19 · VIH/sidapublished 2022PloS onePubMeddocument of 7 observations
3.1 %Among 1988 postpartum mothers in Kenya, 3.1% had moderate/severe depression (MSD) symptoms.
Kenyadépressionpublished 2026AIDS and behaviorPubMeddocument of 8 observations
56 %There was a 56% reduction in uptake of HIV services during the first wave of the COVID-19 pandemic, as indicated by retrospective review of HIV program data from 2018–2020.
KenyaCOVID-19 · VIH/sidaobserved 2018-2020published 2021International journal of environmental research and public healthPubMeddocument of 7 observations
26 %Among 423 HIV-negative Kenyan men who have sex with men and transgender women, quarterly injections were preferred by 26% in pairwise comparisons.
KenyaVIH/sidapublished 2023AIDS and behaviorPubMeddocument of 9 observations
Cervical cancer is currently ranked the highest cause of cancer deaths in Kenya.
Kenyacancer du col de l'utéruspublished 2016Journals & Books Hosting (International Knowledge Sharing Platform)OpenAlexdocument of 18 observations
In Kenya, cervical cancer is the leading cause of cancer-related mortality among women of reproductive age.
Kenyacancer du col de l'utéruspublished 2014BMC public healtheurope_pmcdocument of 2 observations
The prevalence of sporozoite antibodies varied with age among children aged one to nine years resident in a rural area of The Gambia.
Kenyapaludismepublished 1989Annals of tropical medicine and parasitologyeurope_pmcdocument of 4 observations
1.52 hazard_ratioDiabetes mellitus was significantly associated with mortality in patients with moderate to severe pulmonary hypertension, with an adjusted hazard ratio of 1.52.
Kenyadiabète (non précisé) · pulmonary hypertensionpublished 2020Global heartPubMeddocument of 10 observations
29 %29% of children aged 3-59 months experienced fever within 2 weeks before the interview.
Kenyapaludismepublished 2011PLoS medicineeurope_pmcdocument of 3 observationsDOI 10.1371/journal.pmed.1000437
0.9 %Limb lymphedema was present in 0.9% of adult individuals (≥20 years old) in the low endemicity community.
Kenyalimb lymphedemapublished 2002The American journal of tropical medicine and hygieneeurope_pmcdocument of 12 observationsDOI 10.4269/ajtmh.2002.66.550
54 studiesMost of the selected studies on chikungunya fever in children were from Asia (54 out of 142 studies).
Kenyachikungunyapublished 2022PLOS global public healtheurope_pmcdocument of 6 observationsDOI 10.1371/journal.pgph.0000914
11.8 %In Ndhiwa, Kenya, the proportion of people living with HIV (PLHIV) with advanced HIV decreased from 11.8% in 2012 to 5.0% in 2018.
KenyaVIH avancéobserved 2012published 2024Journal of the International Association of Providers of AIDS CarePubMeddocument of 7 observations
0.82 utility_scoreFor uncomplicated malaria, the median utility score was 0.82 using the Ethiopian value set.
Kenyapaludismeobserved June to September 2024published 2025Health and quality of life outcomeseurope_pmcdocument of 8 observations
1,663 individualsA total of 1,663 adolescents aged 10–19 years living with HIV newly initiated antiretroviral therapy at 47 health facilities in central Kenya.
KenyaVIH/sidapublished 2022AIDS research and human retrovirusesPubMeddocument of 18 observations
61.7 %HIV-related knowledge among respondents increased from 61.7% to 90% (p < 0.001).
KenyaVIH/sidapublished 2022Journal of the International AIDS SocietyPubMeddocument of 10 observations
3 casesThree previously reported human PCR-positive cases of MERS-CoV clustered with camel infections in time and place in Northern Kenya.
KenyaMERS-CoVpublished 2022Viruseseurope_pmcdocument of 6 observationsDOI 10.3390/v14081743
A single isolate from Western Kenya contained the PfK13 V568I variant, potentially linked to reduced susceptibility to artemisinin.
Kenyapaludismepublished 2024Scientific reportsPubMeddocument of 3 observations
0.59 %Syphilis accounted for 0.59% of discarded blood units due to transfusion transmissible infections at the Kwale Satellite Blood Transfusion Centre in Kenya from 2018 to 2022.
Kenyasyphilisobserved 2018-2022published 2024BMC public healthPubMeddocument of 7 observations
The 90-90-90 UNAIDS indicators were 60%-68%-83% in Ndhiwa sub-county in 2012.
KenyaVIH/sidaobserved 2012published 2021Tropical medicine & international health : TM & IHPubMeddocument of 7 observations
Every row leads to its source document. The figure shown counts the VALIDATED observations it carries, never the extracted ones: the two differ on most documents. The exact source excerpt is not published, due to copyright constraints.